OTCM
CILJF
Market cap128bUSD
Oct 20, Last price
3.03
Name
China Life Insurance Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Life Insurance Company Limited, along with its affiliated entities, serves as a primary life insurance provider within the People's Republic of China. The firm's business activities are structured into four key divisions: Life Insurance, Health Insurance, Accident Insurance, and a segment designated for Other Businesses. It delivers a wide array of insurance products, such as critical illness coverage, annuity schemes, policies tailored for children, women, and retirement planning, general security, life policies, medical care coverage, and accident protection. Founded in 1949, the company maintains its central operations in Beijing, China, and is a part of the broader China Life Insurance (Group) Company Limited.
Related entities
Parent
中国人寿保险(集团)公司
Subsidiaries (2)
Glorious Fortune Forever Limited
Golden Phoenix Tree Limited
Key people
Xiliang Cai
Executive Chairman of the Board · since 2025
Mingguang Li
President, Executive Director · since 2024
Ying Yuan
Finance Director · since 2024
Chongmiao Xu
Chief Compliance Officer, Compliance Officer · since 2024
Kai Bai
Vice President · since 2023
Yuejin Liu
General Counsel, Deputy General Manager
Qi Ruan
Chief Risk Officer, Vice President, Chief Cyber Security Officer, Executive Director · since 2024
Jin Hou
Chief Actuary · since 2023
Zhijun Hu
Chief Audit Officer · since 2023
Hui Liu
Chief Investment Officer, Vice President, Executive Director, Secretary of the Board · since 2025
Kailong Niu
Director · since 2025
Jin Hu
Non-Executive Director · since 2024
Rong Hu
Non-Executive Director · since 2024
Jie Chen
Independent Director · since 2022
Chi Kuen Lam
Independent Director · since 2021
Feng Lu
Independent Director · since 2024
Independent Director · since 2021
Headquarters & legal address
16 FINANCIAL STREET
XICHENG DISTRICT
BEIJING 100032
CN
XICHENG DISTRICT
BEIJING 100032
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||